Natural Alternatives International (Natural Alternatives International) Debt-to-EBITDA

: -5.58 (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Natural Alternatives International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.5 Mil. Natural Alternatives International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $55.8 Mil. Natural Alternatives International's annualized EBITDA for the quarter that ended in Dec. 2023 was $-10.3 Mil. Natural Alternatives International's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -5.58.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Natural Alternatives International's Debt-to-EBITDA or its related term are showing as below:

NAII' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.99 Med: 2.76 Max: 210.65
Current: 210.65

During the past 13 years, the highest Debt-to-EBITDA Ratio of Natural Alternatives International was 210.65. The lowest was 0.99. And the median was 2.76.

NAII's Debt-to-EBITDA is ranked worse than
99.65% of 1418 companies
in the Consumer Packaged Goods industry
Industry Median: 2.14 vs NAII: 210.65

Natural Alternatives International Debt-to-EBITDA Historical Data

The historical data trend for Natural Alternatives International's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natural Alternatives International Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-EBITDA

12.58

0.99

1.78

3.75

Natural Alternatives International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-EBITDA																2.26	-5.94	1.87	39.46	-5.58

Competitive Comparison

For the Packaged Foods subindustry, Natural Alternatives International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natural Alternatives International Debt-to-EBITDA Distribution

For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Alternatives International's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Natural Alternatives International's Debt-to-EBITDA falls into.

Natural Alternatives International Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Natural Alternatives International's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(2.76	+	28.17)	/	8.256
	=	3.75

Natural Alternatives International's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(1.517	+	55.78)	/	-10.272
	=	-5.58

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.

Natural Alternatives International (NAS:NAII) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Natural Alternatives International Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Natural Alternatives International's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Natural Alternatives International (Natural Alternatives International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Natural Alternatives International Inc (NAS:NAII) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

NA2:Germany

Address

1535 Faraday Avenue, Carlsbad, CA, USA, 92008

Website

https://www.nai-online.com

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Executives

Mark A Ledoux	director, 10 percent owner, officer: CEO/Chairman	1185 LINDA VISTA DR, SAN MARCOS CA 92069
Joe E Davis	director	3436 CARIBETH DR, ENCINO CA 91436
Lee G Weldon	director	1185 LINDA VISTA DRIVE, SAN MARCAS CA 92069
Alan G Dunn	director	1185 LINDA VISTA DR., SUITE A, SAN MARCOS X1 92078
Michael E Fortin	officer: Chief Financial Officer	1185 LINDA VISTA DRIVE, SAN MARCOS CA 92078
Kenneth Wolf	officer: Chief Financial Officer	12626 HIGH BLUFF DRIVE, SUITE 440, SAN DIEGO CA 92130
Alan J Lane	director	41090 AVENIDA VERDE, TEMECULA CA 92591
Guru Ramanathan	director	C/O GNC HOLDINGS, INC., 300 SIXTH AVENUE, PITTSBURGH PA 15222
Laura Kay Matherly	director	1535 FARADAY AVENUE, CARLSBAD CA 92008
Edward Borg	10 percent owner	600 SOUTH US HIGHWAY 1, APT. 609, JUPITER FL 33477
Alvin Mccurdy	officer: V.P. of Operations	1185 LINDA VISTA DR., SUITE A, SAN MARCOS CA 92078
Carl J Terranova	other: Member of 13(d) 10% group	159 CHRYSTIE ST, NEW YORK NY 10002
Thomas H Hansen	10 percent owner
John Dullea	officer: President, RHL (Subsidiary)	12189 CAMINITO CORRIENTE, SAN DIEGO CA 92128
Randell Weaver	officer: President